4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-001893
CEO sold 22,430 shares at an average $76.67 ($1,719,741)
- CEO acquired 25,350 shares (option exercise)
- CEO gave 2,920 shares (gift)
- CEO gave 2,920 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Zovighian Bernard J · CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Exercise or conversion : show line 1 in the form | +25,350 | $59.26 | $1,502,157 | 106,326 | D |
| 2026-02-12 | Sale : show line 2 in the form | −2,532 | $77.13 | $195,290 | 103,794 | D |
| 2026-02-12 | Sale : show line 3 in the form | −19,898 | $76.61 | $1,524,451 | 83,896 | D |
| 2026-02-13 | Gift : show line 4 in the form | −2,920 | 80,976 | D | ||
| 2026-02-13 | Gift : show line 5 in the form | +2,920 | 11,516.55 | I | ||
| Open-market sales · 22,430 sh · avg $76.67 · $1,719,741 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Acquire) | −25,350 | 0 | D |
Loading xslF345X05/doc4.xml…